seed
Stage
1
Investors
About
AMR Bio is a clinical‑stage biotechnology company developing novel anti‑infective therapeutics. The company is focused on advancing clinical candidates for treating infectious diseases.
Explore AMR Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.